Drugs to Treat Bone Metastases

Some men diagnosed with prostate cancer will have their cancer spread (metastasize) to other parts of the body. The bones are a common place for cancer to spread.

Two classes of drugs used to treat cancer that has spread to the bone are:
  1. Bisphosphonates: prevent loss of bone mass
  2. Denosumab: block osteoclasts (bone cells) from breaking down bone

Everyone responds to therapies for treating bone metastases differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.

Below are common drugs used to treat bone metastases. Click on each drug name for further information including:
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Alendronate (Fosamax®)

Denosumab (Xgeva®)

Pamidronate (Aredia®)

Zoledronic Acid (Zometa®) 

Last Reviewed: July 2017

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive